Andy Chevigné and his group, RTI-5152-twelve is postulated to raise the levels of opioid peptides that bind to classical opioid receptors while in the Mind, causing heightened painkilling action. The LIH-RTI study teams recognized a collaboration agreement and submitted a joint patent application in December 2020.Distributing this assessment signi